Sonic Healthcare Limited (SKHHY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Sonic Healthcare Limited (SKHHY) trades at $15.13. Sonic Healthcare Limited is a global medical diagnostics company providing laboratory and radiology services. Market cap: $7.48B, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for SKHHY: SKHHY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SKHHY against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SKHHY: 1/1 perspectives are bearish.
How is this calculated? →Sonic Healthcare Limited (SKHHY) Healthcare & Pipeline Overview
Sonic Healthcare Limited is a global medical diagnostics company providing comprehensive pathology and radiology services to clinicians, hospitals, and community health services. Operating across multiple geographies, including Australia, the United States, and Europe, Sonic Healthcare plays a crucial role in healthcare delivery through its diagnostic capabilities.
What Is the Investment Thesis for SKHHY?
Sonic Healthcare Limited presents a compelling investment case based on its established market position and consistent financial performance. With a P/E ratio of 18.97 and a dividend yield of 5.21%, the company demonstrates stable profitability and shareholder returns. A gross margin of 29.6% and a profit margin of 5.2% indicate efficient operations. Key growth catalysts include the increasing demand for diagnostic services and expansion into new geographic markets. However, potential risks include regulatory changes and competition from other diagnostic service providers. The company's beta of 0.54 suggests lower volatility compared to the broader market, making it a potentially stable investment.
Based on FMP financials and quantitative analysis
SKHHY Key Highlights
- Market capitalization of $7.48B reflects Sonic Healthcare's significant presence in the medical diagnostics industry.
- P/E ratio of 18.97 indicates a reasonable valuation relative to earnings.
- Dividend yield of 5.21% provides a substantial income stream for investors.
- Gross margin of 29.6% demonstrates the company's ability to manage its cost of goods sold effectively.
- Beta of 0.54 suggests lower volatility compared to the overall market.
Who Are SKHHY's Competitors?
SKHHY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CNVVF ConvaTec Group Plc | $2.73 | +0.00% | $5.32B | 49 |
| CNVVY ConvaTec Group Plc | $11.74 | +0.41% | $5.74B | 43 |
| DSRLF DiaSorin S.p.A. | $84.10 | +13.27% | $4.16B | 52 |
| GNGBY Getinge AB (publ) | $21.24 | +0.80% | $5.78B | 47 |
| MSMKF MatsukiyoCocokara & Co. | $14.60 | +0.00% | $5.74B | 49 |
| PRE Prenetics Global Limited | $17.25 | +1.88% | $293.23M | 69 |
| EPGNY Epigenomics AG | $2.39 | +0.00% | 68 | |
| STRRP Star Equity Holdings, Inc. | $9.89 | -0.10% | $40.58M | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SKHHY's Key Strengths?
- Comprehensive range of diagnostic services.
- Global presence and geographic diversification.
- Established brand reputation.
- Extensive network of medical laboratories and imaging centers.
What Are SKHHY's Weaknesses?
- Exposure to regulatory changes in multiple countries.
- Dependence on healthcare provider relationships.
- Potential for technological obsolescence.
- Currency risk due to international operations.
What Could Drive SKHHY Stock Higher?
- Increasing demand for diagnostic services due to an aging population and rising prevalence of chronic diseases.
- Expansion into new geographic markets, particularly in emerging economies.
- Potential acquisitions of smaller diagnostic service providers to expand market share.
- Technological advancements in diagnostic technologies, such as molecular diagnostics and personalized medicine.
- Strategic partnerships with healthcare providers to enhance market access and service delivery.
What Are the Key Risks for SKHHY?
- Regulatory changes in multiple countries affecting diagnostic service operations.
- Economic downturns reducing healthcare spending and diagnostic service demand.
- Competition from other diagnostic service providers.
- Data security and privacy breaches compromising patient information.
- Currency risk due to international operations.
What Are the Growth Opportunities for SKHHY?
- Expansion into Emerging Markets: Sonic Healthcare has the opportunity to expand its operations into emerging markets with growing healthcare needs. These markets often lack advanced diagnostic infrastructure, presenting a significant opportunity for Sonic Healthcare to establish a presence and capture market share. The timeline for this expansion could be within the next 3-5 years, with a potential market size of several billion dollars.
- Increased Demand for Diagnostic Services: The increasing prevalence of chronic diseases and an aging global population are driving demand for diagnostic services. Sonic Healthcare is well-positioned to capitalize on this trend by expanding its service offerings and investing in advanced diagnostic technologies. This is an ongoing opportunity with a continuously expanding market size.
- Technological Advancements in Diagnostics: Advancements in diagnostic technologies, such as molecular diagnostics and personalized medicine, are creating new opportunities for Sonic Healthcare. By investing in these technologies, the company can enhance its service offerings and improve diagnostic accuracy. The timeline for realizing these opportunities is within the next 2-3 years.
- Strategic Acquisitions: Sonic Healthcare can pursue strategic acquisitions to expand its geographic reach and service offerings. Acquiring smaller diagnostic service providers in key markets can provide access to new customers and technologies. The timeline for potential acquisitions is ongoing, with the market size depending on the specific targets.
- Partnerships with Healthcare Providers: Collaborating with hospitals, clinics, and other healthcare providers can enhance Sonic Healthcare's market access and service delivery. By forming strategic partnerships, the company can integrate its diagnostic services into the broader healthcare ecosystem. This is an ongoing opportunity with a continuously expanding market size.
What Opportunities Does SKHHY Have?
- Expansion into emerging markets.
- Increased demand for diagnostic services.
- Technological advancements in diagnostics.
- Strategic acquisitions.
What Threats Does SKHHY Face?
- Competition from other diagnostic service providers.
- Economic downturns affecting healthcare spending.
- Changes in healthcare reimbursement policies.
- Data security and privacy breaches.
What Are SKHHY's Competitive Advantages?
- Established brand reputation and long-standing relationships with healthcare providers.
- Extensive network of medical laboratories and imaging centers.
- Comprehensive range of diagnostic services.
- Global presence and geographic diversification.
What Does SKHHY Do?
Sonic Healthcare Limited, established in 1934 and headquartered in Sydney, Australia, is a leading international medical diagnostics company. The company provides a wide array of services, including laboratory medicine/pathology and diagnostic imaging/radiology. Its radiology services encompass magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Sonic Healthcare also offers primary care medical services, including general practice, occupational health, remote health, community and home nursing, research programs, health assessment technologies, clinical trials, and chronic disease management. Sonic Healthcare serves a diverse clientele, including clinicians, hospitals, community health services, and patients. With operations spanning Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland, the company has established a significant global presence. Its comprehensive service offerings and broad geographic reach position Sonic Healthcare as a key player in the medical diagnostics industry. The company also provides administrative services and facilities to medical practitioners, further integrating its services within the healthcare ecosystem.
What Products and Services Does SKHHY Offer?
- Provides laboratory medicine/pathology services.
- Offers diagnostic imaging/radiology services, including MRI, CT, and X-ray.
- Delivers primary care medical services, including general practice and occupational health.
- Offers remote health services and community and home nursing.
- Conducts primary care research programs and clinical trials.
- Provides health assessment technologies and chronic disease management programs.
- Offers administrative services and facilities to medical practitioners.
How Does SKHHY Make Money?
- Generates revenue through fees for diagnostic testing and imaging services.
- Contracts with hospitals, clinics, and other healthcare providers to provide diagnostic services.
- Operates a network of medical laboratories and imaging centers.
- Provides administrative services to medical practitioners for a fee.
What Industry Does SKHHY Operate In?
Sonic Healthcare operates within the medical diagnostics and research industry, a sector characterized by continuous technological advancements and increasing demand for accurate and timely diagnostic information. The industry is driven by factors such as an aging population, the rising prevalence of chronic diseases, and advancements in medical technology. Sonic Healthcare competes with other diagnostic service providers, including CNVVF (Clover Health Investments Corp), CNVVY (Clover Health Investments Corp), DSRLF (DShare Health), GNGBY (Guardant Health Inc), and MSMKF (Medica Holding SA), in a fragmented market. The company's comprehensive service offerings and global presence provide a competitive edge.
Who Are SKHHY's Key Customers?
- Clinicians who order diagnostic tests for their patients.
- Hospitals that require diagnostic services for their patients.
- Community health services that provide diagnostic testing to the public.
- Patients who directly access diagnostic services.
F-Score 6/9Financial Health
Sonic Healthcare Limited's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.29 places it in the grey zone, a middle ground that warrants monitoring.
ROE 6%Key Financial Metrics
Return on equity for Sonic Healthcare Limited stands at 6.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.2%, showing how much profit it generates from its asset base. SKHHY trades at a trailing price-to-earnings ratio of 19.16, below the Healthcare sector average of ~23x. Its free cash flow yield is 8.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.01 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.2%, the inverse of the P/E and a quick read on earnings relative to price.
Sonic Healthcare Limited (SKHHY) Valuation Context
Valued at $7.48B, SKHHY is classified as a mid-cap stock.
FY2026 estForward Outlook
Wall Street analysts project Sonic Healthcare Limited revenue of about $11.25B for fiscal 2026, with EPS near $1.26. The estimate reflects 8 contributing analysts.
SKHHY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying indicates confidence from leadership, suggesting strong belief in the company's future performance.
- Community sentiment has shifted positively as discussions highlight Sonic's resilience during market fluctuations, enhancing investor trust.
- Sonic's reputation for quality healthcare services has been reinforced by recent accolades, boosting brand perception among investors.
- The ongoing demand for healthcare services, especially post-pandemic, positions Sonic well for sustained growth in a vital sector.
Bear Case
- Some investors express concern over potential regulatory changes impacting the healthcare sector, which could affect operational flexibility.
- Recent discussions reflect worries about rising operational costs, which may squeeze margins and impact profitability in the near term.
- Community sentiment shows skepticism regarding the company's ability to maintain growth momentum amid increasing competition in the healthcare industry.
- Concerns over global economic conditions may lead to reduced healthcare spending, impacting Sonic's revenue streams and overall performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SKHHY Latest News
No recent news available for SKHHY.
SKHHY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SKHHY.
Price Targets
Wall Street price target analysis for SKHHY.
SKHHY MoonshotScore
What does this score mean?
The MoonshotScore rates SKHHY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: James Pacey Newcombe
Managing Director
James Pacey Newcombe is the Managing Director of Sonic Healthcare Limited. His leadership guides the company's strategic direction and operational execution across its global network. Information regarding his specific educational background and previous roles is not available in the provided data. However, his current position indicates extensive experience in the healthcare and diagnostics industry.
Track Record: Under James Pacey Newcombe's leadership, Sonic Healthcare Limited manages a workforce of 42,000 employees. Specific milestones and strategic decisions under his tenure are not detailed in the provided data. However, his role as Managing Director suggests a significant influence on the company's growth and performance.
Sonic Healthcare Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. SKHHY is a Level 1 ADR, meaning it trades over-the-counter (OTC) rather than on a major exchange. This allows U.S. investors to invest in Sonic Healthcare without directly dealing with foreign markets.
- Home Market Ticker: Australian Securities Exchange (ASX), Australia
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: SKHH
SKHHY OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and transparency compared to exchange-listed securities. These companies may not be current in their reporting requirements.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to OTC Other tier status.
- Potential for fraud or manipulation due to lack of regulatory oversight.
- Low liquidity and wide bid-ask spreads.
- Higher price volatility compared to exchange-listed stocks.
- Risk of delisting or suspension from the OTC market.
- Verify the company's registration and legal status.
- Attempt to obtain and review any available financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before investing.
- Check for any news or regulatory actions related to the company.
- Established operations in multiple countries.
- Long operating history since 1934.
- Presence in the healthcare sector, which is subject to regulatory oversight.
- ADR listing, indicating some level of compliance with U.S. regulations.
What Investors Ask About Sonic Healthcare Limited (SKHHY) — Healthcare
What does Sonic Healthcare Limited do?
Sonic Healthcare Limited is a global medical diagnostics company that provides a comprehensive range of laboratory medicine/pathology and diagnostic imaging/radiology services. The company serves clinicians, hospitals, community health services, and patients across multiple countries, including Australia, the United States, and Europe. Sonic Healthcare also offers primary care medical services and administrative support to medical practitioners, positioning itself as a key player in the healthcare ecosystem.
What are the main risks for SKHHY?
The main risks for Sonic Healthcare Limited include regulatory changes in the various countries where it operates, potential economic downturns affecting healthcare spending, and competition from other diagnostic service providers. Data security and privacy breaches also pose a significant risk, as the company handles sensitive patient information. Additionally, currency risk due to international operations can impact financial performance.
What are the key factors to evaluate for SKHHY?
Evaluate SKHHY on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does SKHHY data refresh on this page?
SKHHY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SKHHY's recent stock price performance?
Sonic Healthcare Limited (SKHHY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive range of diagnostic services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SKHHY overvalued or undervalued right now?
Valuing Sonic Healthcare Limited (SKHHY) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SKHHY?
Before investing in Sonic Healthcare Limited (SKHHY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding SKHHY to a portfolio?
Key strength of Sonic Healthcare Limited (SKHHY): Comprehensive range of diagnostic services. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may not be exhaustive.
- AI analysis is pending and may provide further insights.